Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Research article

Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch - results from a representative cross-sectional study

Authors: Elke Weisshaar, Melanie Weiss, Jutta Passlick-Deetjen, Ulrich Tschulena, Klaudia Maleki, Thomas Mettang

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

A representative cross-sectional study showed that chronic itch (lasting for a minimum of 6 weeks) affects 25.2 % (point prevalence) of hemodialysis (HD) patients. Pathophysiology and etiology of chronic itch (CI) in HD are still unclear.

Methods

We investigated 860 HD patients from a representative randomly selected cluster-sample considering the regional distributions of dialysis units in GermanyThe current analyses report comorbidities, laboratory values and dialysis characteristics of HD patients in relation to CI.

Results

Diabetes was the only comorbidity that was associated with the occurrence of itch but interestingly with less CI. Except for creatinine, phosphorus, and parathormone, there were no significant associations between the occurrence and characteristics of CI and any laboratory value. Kt/V was not associated with the presence of CI. Patients dialyzed with polyarylethersulfone-membrane showed significantly more CI in all prevalence estimates and those dialyzed with polysulfone-membrane were significantly less affected by CI.

Conclusions

Long-term follow-up studies will show if the type of dialysis membrane influences the development of CI in HD patients. It is most likely that several factors e.g. elevated parathormone, origin of end stage renal disease (ESRD), type of dialysis membrane, and a neuropathic component all contribute to the occurrence of CI in HD patients. Future research should consider a multifactorial origin of itch in HD.
Literature
1.
go back to reference Weiss M, Mettang T, Tschulena U, Passlick-Deetjen J, Weisshaar E. Prevalence of chronic itch and associated factors in hemodialysis patients – Results from a representative cross-sectional study. Acta Derm Venereol 2015; 2015 Mar 5. doi: 10.2340/00015555-2087. (Epub ahead of print). Weiss M, Mettang T, Tschulena U, Passlick-Deetjen J, Weisshaar E. Prevalence of chronic itch and associated factors in hemodialysis patients – Results from a representative cross-sectional study. Acta Derm Venereol 2015; 2015 Mar 5. doi: 10.​2340/​00015555-2087. (Epub ahead of print).
2.
go back to reference Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87(4):291–4.CrossRefPubMed Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87(4):291–4.CrossRefPubMed
3.
go back to reference Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.CrossRefPubMed Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.CrossRefPubMed
4.
go back to reference Mistik S, Utas S, Ferahbas A, Tokgoz B, Unsal G, Sahan H, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol. 2006;20(6):672–8.CrossRefPubMed Mistik S, Utas S, Ferahbas A, Tokgoz B, Unsal G, Sahan H, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol. 2006;20(6):672–8.CrossRefPubMed
5.
go back to reference Kimata N, Fuller DS, Saito A, Akizawa T, Fukuhara S, Pisoni RL, et al. Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). Hemodial Int. 2014;18(3):657–67.CrossRefPubMed Kimata N, Fuller DS, Saito A, Akizawa T, Fukuhara S, Pisoni RL, et al. Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). Hemodial Int. 2014;18(3):657–67.CrossRefPubMed
6.
go back to reference Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol. 1997;36(4):538–43.CrossRefPubMed Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol. 1997;36(4):538–43.CrossRefPubMed
7.
go back to reference Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol. 2006;66(3):184–91.CrossRefPubMed Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol. 2006;66(3):184–91.CrossRefPubMed
8.
go back to reference Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostioc significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Intl. 2006;69:1626–32.CrossRef Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostioc significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Intl. 2006;69:1626–32.CrossRef
9.
go back to reference Ko MJ, Wu HY, Chen HY, Chiu YL, Hsu SP, Pai MF, et al. Uraemic pruritus, dialysis adequacy and metabolic profies in hemodialysis patients: a preosepctive 5-year cohort study. PLoS One. 2013;8:e71404.PubMedCentralCrossRefPubMed Ko MJ, Wu HY, Chen HY, Chiu YL, Hsu SP, Pai MF, et al. Uraemic pruritus, dialysis adequacy and metabolic profies in hemodialysis patients: a preosepctive 5-year cohort study. PLoS One. 2013;8:e71404.PubMedCentralCrossRefPubMed
10.
go back to reference Bergamo Collaborative Dialysis Study Group. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int. 1991;40(4):714–9.CrossRef Bergamo Collaborative Dialysis Study Group. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int. 1991;40(4):714–9.CrossRef
11.
go back to reference Szepietowski JC, Sikora M, Kusztal M, Salomon J, Magott M, Szepietowski T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol. 2002;29(10):621–7.CrossRefPubMed Szepietowski JC, Sikora M, Kusztal M, Salomon J, Magott M, Szepietowski T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol. 2002;29(10):621–7.CrossRefPubMed
12.
go back to reference Aucella F, Gesuete A. Uremic pruritus: an unresolved challenge. G Ital Nefrol. 2009;S26(5):585–99. Aucella F, Gesuete A. Uremic pruritus: an unresolved challenge. G Ital Nefrol. 2009;S26(5):585–99.
13.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800–4.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800–4.CrossRef
14.
go back to reference Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92(5):497–501.CrossRefPubMed Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92(5):497–501.CrossRefPubMed
15.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
16.
go back to reference Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003;42(1):125–32.CrossRefPubMed Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003;42(1):125–32.CrossRefPubMed
17.
go back to reference Kovacic V, Roguljic L, Jukic I, Kovacic V. Comparison of methods for hemodialysis dose calculation. Dialysis Transplant. 2003;32(4):170–8. Kovacic V, Roguljic L, Jukic I, Kovacic V. Comparison of methods for hemodialysis dose calculation. Dialysis Transplant. 2003;32(4):170–8.
19.
go back to reference Weisshaar E, Matterne U, Mettang T. How do nephrologists in haemodialysis units consider the symptom of itch? Results of a survey in Germany. Nephrol Dial Transplant. 2009;24(4):1328–30.CrossRefPubMed Weisshaar E, Matterne U, Mettang T. How do nephrologists in haemodialysis units consider the symptom of itch? Results of a survey in Germany. Nephrol Dial Transplant. 2009;24(4):1328–30.CrossRefPubMed
20.
go back to reference Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol. 2009;89(4):339–50.CrossRefPubMed Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol. 2009;89(4):339–50.CrossRefPubMed
22.
go back to reference Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1410–9.PubMedCentralCrossRefPubMed Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1410–9.PubMedCentralCrossRefPubMed
23.
go back to reference Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995;25(3):413–9.CrossRefPubMed Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995;25(3):413–9.CrossRefPubMed
24.
go back to reference Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49(5):842–6.CrossRefPubMed Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49(5):842–6.CrossRefPubMed
25.
go back to reference Hampers CL, Katz AI, Wilson RE, Merrill JP. Disappearance of “uremic” itching after subtotal parathyroidectomy. N Engl J Med. 1968;279(13):695–7.CrossRefPubMed Hampers CL, Katz AI, Wilson RE, Merrill JP. Disappearance of “uremic” itching after subtotal parathyroidectomy. N Engl J Med. 1968;279(13):695–7.CrossRefPubMed
26.
go back to reference Stahle-Bäckdahl MO, Hägermark LE, Lins O, Törring M, Hilliges O. Johansson: experimental and immunohistochemical studies on the possible role of parathyroid hormone in uremic pruritus. J Intern Med. 1989;225(6):411–5.CrossRefPubMed Stahle-Bäckdahl MO, Hägermark LE, Lins O, Törring M, Hilliges O. Johansson: experimental and immunohistochemical studies on the possible role of parathyroid hormone in uremic pruritus. J Intern Med. 1989;225(6):411–5.CrossRefPubMed
27.
go back to reference Virga G, Visentin I, La Milia V, Bonadonna A. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant. 2002;17(12):2164–9.CrossRefPubMed Virga G, Visentin I, La Milia V, Bonadonna A. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant. 2002;17(12):2164–9.CrossRefPubMed
28.
go back to reference Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in hemodialysis. Nephrol Dial Transplant. 2006;21(3):749–55.CrossRefPubMed Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in hemodialysis. Nephrol Dial Transplant. 2006;21(3):749–55.CrossRefPubMed
29.
30.
go back to reference Phillips WG. Pruritus. What to do when the itching won’t stop. Postgrad Med. 1992;92(7):39–40. Phillips WG. Pruritus. What to do when the itching won’t stop. Postgrad Med. 1992;92(7):39–40.
31.
go back to reference Matterne U, Apfelbacher CJ, Vogelgsang L, Loerbroks A, Weisshaar E. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol. 2013;93(5):532–7.CrossRefPubMed Matterne U, Apfelbacher CJ, Vogelgsang L, Loerbroks A, Weisshaar E. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol. 2013;93(5):532–7.CrossRefPubMed
Metadata
Title
Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch - results from a representative cross-sectional study
Authors
Elke Weisshaar
Melanie Weiss
Jutta Passlick-Deetjen
Ulrich Tschulena
Klaudia Maleki
Thomas Mettang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0177-3

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.